GC Cell Corp

144510

Company Profile

  • Business description

    GC Cell Corp engages in the provision of anti-cancer immunotherapy. The company is developing an anticancer drug, which is in Phase II clinical trials; and stem cell treatment drugs. It also provides cell banking, sample inspection, clinical trial, and bio logistics services.

  • Contact

    30 beongil to giheung-gu
    Gyeonggi
    107 Lee Hyun
    Yongin16 924
    KOR

    T: +82 312609600

    https://www.gccell.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 December 2025

    Employees

    797

Stocks News & Analysis

stocks

Strong finish to the year for overvalued ASX share

A great fiscal 2025 but investors are ahead of themselves.
stocks

Our three most overvalued ASX shares

These three companies are trading at a significant premium to our fair value.
stocks

What does big US court decision mean for Google’s parent company Alphabet?

Alphabet shares popped 7% after the ruling on September 2 and have now rallied by around 50% since April.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,080.7039.80-0.44%
CAC 407,763.4728.630.37%
DAX 4023,718.8488.29-0.37%
Dow JONES (US)45,514.95114.090.25%
FTSE 1009,241.6220.180.22%
HKSE25,938.13304.221.19%
NASDAQ21,798.7098.310.45%
Nikkei 22543,459.29184.52-0.42%
NZX 50 Index13,253.7327.41-0.21%
S&P 5006,495.1513.650.21%
S&P/ASX 2008,803.5037.40-0.42%
SSE Composite Index3,807.2919.55-0.51%

Market Movers